119sek
7,7 %
Date:2025-05-16Time:18:00:00Latest report:Q1-2025List:First NorthTicker:ICO
Market Cap:25 msekEnterprise Value:21 msekNet Sales:1,70 msekEarnings:-42,8 msekEmployees:0ISIN:SE0010868943

Ratios

10-year key figure history for Iconovo turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Iconovo with index and moving average MA50 and MA200.

Stockprice:1,19
MA50:2,29
MA200:4,78
Price/MA200:-75,1 %
RSI (14):36,1
Price/MA50:-48,1 %

Description

Iconovo is a medical technology company. The company develops inhalers for medical use. The company's products are used in the treatment of asthma and carbon monoxide, where the inhalers consist of powder-based medicine. The products are licensed and sold under various brands. In addition to product development, there is expertise in pharmaceutical formulation. The company was founded in 2013 and is headquartered in Lund.

Medical Equipment